This post was originally published on this site
(FILES) In this file photo taken on September 1, 2019 Roundup weed killer, that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California
mark ralston/Agence France-Presse/Getty Images
Bayer’s BAYN, -2.74% $10.9 billion settlement to resolve lawsuits over the safety of its Roundup weedkiller is stalling, plaintiffs’ attorneys said Thursday in court.
The German chemical and pharmaceutical giant said in June it had reached deals to settle 75% of the 125,000 cases alleging its popular weedkiller causes cancer and was working to tie up the rest. Shareholders welcomed the news after three California juries returned massive awards against the company in Roundup trials. Bayer says Roundup is safe and doesn’t cause non-Hodgkin lymphoma.
